跳至主要内容
临床试验/CTRI/2023/01/048772
CTRI/2023/01/048772招募中2 期

To Study the Effect of Aarogyavardhini Vati and Triphala Kwath Against Navak Guggulu and Triphala Kwath in Sthaulya with special reference to Obesity: Randomized control Study.

Government Ayurved College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients having clinical features of Sthaulya ( >50%) according to classics.
  • 2.Patients of Sthaulya having BMI more than 25Kg/m2 and less than 40Kg/m2.
  • 3.Patients of either sex of age between 18- 60 years are included.
  • 4.Those patients of Sthaulya who are willing to participate in study and ready to give written consent will be included.
  • 5.Patient who had not participated in any research work since last six months will be included.

排除标准

  • 1.Patients of Sthaulya having BMI less than 25Kg/m2 and more than 40Kg/m2 will be excluded.
  • 2.Patients having age below 18yrs and above 60yrs will be excluded.
  • 3.Patients of Obesity due to hypothyroidism and Obesity with having clinical history of any other systemic disorders like Ischemic heart disease Patients with complicated and chronic disorder like Nephrotic syndrome, Jaundice, Hepatitis, chronic infections and other serious diseases will be excluded.
  • 4.Patients of Sthaulya with uncontrolled hypertension (systolic BP >140mmHg and diastolic BP >100mmHg) and uncontrolled diabetes (Fasting >130mg/dl and Post meal >200mg/dl) mellitus will be excluded.
  • 5.Patients of drug induced Obesity for example Hormonal replacement therapy, consumption of anabolic steroids etc. and any drugs that may influence on the outcome of the study will be excluded.
  • 6.Pregnant females & lactating mothers will be excluded.
  • 7.Patients who are currently participating in other clinical trials (since last six months) will be excluded.
  • 8.Patient with evidence of malignancy.

研究者

发起方
Government Ayurved College and Hospital

相似试验

Study of Aarogyavardhini Vati and Navak Guggulu with... | 临床试验